TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 299 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $329 | +5.4% | 20,000 | 0.0% | 0.38% | -13.5% |
| Q4 2022 | $312 | -99.9% | 20,000 | -55.6% | 0.44% | +7.9% |
| Q3 2022 | $583,000 | -74.8% | 45,000 | -73.5% | 0.40% | -67.4% |
| Q4 2021 | $2,310,000 | -51.5% | 169,500 | -41.7% | 1.24% | -44.0% |
| Q3 2021 | $4,762,000 | +71.9% | 290,753 | +76.6% | 2.21% | +99.8% |
| Q2 2021 | $2,770,000 | +47.3% | 164,610 | +59.8% | 1.11% | +57.8% |
| Q1 2021 | $1,880,000 | +105.9% | 102,988 | +101.1% | 0.70% | +81.6% |
| Q3 2020 | $913,000 | +234.4% | 51,200 | +184.4% | 0.39% | +85.6% |
| Q1 2020 | $273,000 | – | 18,000 | +1799900.0% | 0.21% | – |
| Q3 2019 | $0 | -100.0% | 1 | -100.0% | 0.00% | -100.0% |
| Q2 2019 | $38,000 | -97.8% | 2,200 | -97.4% | 0.01% | -98.1% |
| Q1 2019 | $1,714,000 | +171300.0% | 84,146 | +140143.3% | 0.59% | – |
| Q4 2018 | $1,000 | -100.0% | 60 | -100.0% | 0.00% | -100.0% |
| Q3 2018 | $3,123,000 | +66.9% | 146,156 | +63.1% | 0.73% | -2.0% |
| Q2 2018 | $1,871,000 | – | 89,600 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |